Greater China
Pharma companies are also increasingly turning to AI to accelerate research and development.
1
Small biotech firms quicker to 'latch onto' AI than big ones: Tencent's Alex Ng
2
Himalaya Wealth Managers launches SME fund, eyes $52m corpus
3
EQT, Google Cloud join hands for AI rollout
4
South Korean government-led fund to invest $533m in FuriosaAI
5
HDFC Capital ropes in Development Bank of Japan as LP for real estate PE fund
More Stories
Strategic exits to outpace IPOs in Vietnam’s F&B sector: Maestro Equity
Stablecoins’ second wave is hitting mainstream finance, as capital shifts to the rails
EQT veterans appointed as co-heads for Asia private equity business
India: Healthworld Hospitals ropes in Merfin Advisors to raise $25m amid Tier II push
Vietnam’s Pharmacity secures growth capital from LeapFrog Investments
ByteDance currently sources CPUs from Intel and AMD.
Singapore
The rise in AI bets comes amid overall declining deal value in Singapore.
Philippines
Southeast Asia is increasingly becoming a proving ground for stablecoin-based payments.
Vietnam
Strategic sales remain the more realistic and attractive exit channel.
China wealth and a 2025 IPO boom made Hong Kong an offshore wealth hub.
As exit challenges persist, the baton is increasingly being passed locally, albeit in a different form.
It has launched a technology fund to invest in AI-focused managers and deals.
Part of CATL’s advantage lies in its early investment in EV batteries.
Myanmar
Also read about startup funding in Greater China in Q1 2026.
